Liberation Bioindustries key facts
as of Oct 2026- Developer of an industrial biotechnology system designed to address the growing fermentation capacity gap in cellular agriculture.
- Liberation Bioindustries is valued at approximately $178.0M as of Oct 2026, set at its early-stage round, Dec 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $132.2M across 1 recorded rounds; the latest was Later Stage VC ($60.2M) in Nov 2025.
- Notable investors include Siddhi Capital, CPT Capital, Meach Cove Capital, Echo Investment Capital, Agronomics — 9 tracked in total.
- Liberation Bioindustries has filed 1 Form D with the SEC, most recently Dec 2025 ($60.2M sold to 7 investors).
- Status: Privately Held (backing).
Valued at $178.0M at its early-stage round, Dec 2025. Nothing has traded since.
- ·Watch Liberation Bioindustries: the Monday email on marks, rounds and moves
Liberation Bioindustries funding rounds
1 roundsLiberation Bioindustries valuation
Liberation Bioindustries was valued at $178 million at its early-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Liberation Bioindustries raised?
Liberation Bioindustries has raised $132 million in total; 1 of its rounds is on record. The largest on record was a $60.2 million later-stage round in Nov 2025.
Liberation Bioindustries has filed 1 Form D with the SEC, most recently in Dec 2025 ($60.2 million sold to 7 investors).
Liberation Bioindustries investors
9 investors are on record for Liberation Bioindustries, including Siddhi Capital, CPT Capital, Meach Cove Capital and Echo Investment Capital. The later-stage round in Nov 2025 drew 7 investors.
About Liberation Bioindustries
Developer of an industrial biotechnology system designed to address the growing fermentation capacity gap in cellular agriculture. The company engages in infrastructure that commercializes novel protein manufacturing at the scale and cost structure required by the market, enabling biology innovators to achieve price parity with animal protein and customers to access healthy foods.
- Sector
- Business Products and Services (B2B)
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 19
- Website
- liberation.bio/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.